衍生
发表于 2025-3-23 13:18:11
Management of Glaucoma Associated with Boston KPro Type I Implantationsurgery and is associated with poorer postoperative outcomes. Pathophysiologic factors include underlying disease process, synechial angle closure, steroid-response intraocular pressure (IOP) elevation, and possible pupillary block. Frequent monitoring with structural and functional testing measures
一个搅动不安
发表于 2025-3-23 14:06:27
Boston KPro Type 1: The Role of the Contact Lensafter surgery is a Kontur© Precision Sphere with a 16.0 mm diameter, 9.8 mm base curve, and plano power. Proper centration of the lens and complete corneal coverage are essential for a proper fit, lens retention, and ocular protection. Over-refraction should be measured at each visit and power chang
过去分词
发表于 2025-3-23 21:20:18
Boston KPro Type I: Vitreoretinal Considerations. As the use of KPro increases dramatically, so too does the frequency of posterior segment complications seen by the vitreoretinal surgeon in this patient population, as well as the importance of addressing them expeditiously. Special consideration in diagnostic imaging and surgical planning is req
胆汁
发表于 2025-3-24 02:02:54
http://reply.papertrans.cn/55/5425/542434/542434_14.png
Compassionate
发表于 2025-3-24 03:35:37
Keratoprostheses in the Setting of Autoimmune Disorderstions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, micr
CONE
发表于 2025-3-24 08:56:46
http://reply.papertrans.cn/55/5425/542434/542434_16.png
反对
发表于 2025-3-24 13:07:43
José L. Güell MD, PhD,Elena Arrondo,M. Soledad Cortina MD,Jaime Echevarría,Maria V. Gómez-Resa,Oscarular. We establish the correspondence between evidence-based health care and translational effectiveness, which, as defined by AHRQ, represents the utilization of the best available evidence in clinical settings. We discuss the process of evidence-based health care and translational effectiveness in
Halfhearted
发表于 2025-3-24 17:11:33
Ahmad A. Aref MD,Thasarat S. Vajaranant MDcondition (diagnosis) (.., prevalence, sensitivity, specificity) or from monitoring its course (i.e., prognosis) (.., prevalence and relative prevalence in cross-sectional observation studies, incidence in cohort studies, and experimental designs including clinical trials). The process of quantifica
Goblet-Cells
发表于 2025-3-24 21:58:55
http://reply.papertrans.cn/55/5425/542434/542434_19.png
Diverticulitis
发表于 2025-3-24 23:38:10
http://reply.papertrans.cn/55/5425/542434/542434_20.png